View all video statements held in occasion of half-year and full-year results.
Quarterly CEO statement Q1 - 2026/27
Ypsomed is off to a strong start in 2026/27
- Strong Q1 with 14 new customer projects, exceeding last year's average.
- Growth driven by large-volume autoinjectors, biosimilars, and new indications.
- Innovation recognized with two international product awards.
- Capacity expansion progressing on schedule in Solothurn and Schwerin.
- Manufacturing investments support future growth and scalability.
Ypsomed is off to a strong start in 2026/27
- Strong Q1 with 14 new customer projects, exceeding last year's average.
- Growth driven by large-volume autoinjectors, biosimilars, and new indications.
- Innovation recognized with two international product awards.
- Capacity expansion progressing on schedule in Solothurn and Schwerin.
- Manufacturing investments support future growth and scalability.
Full-Year Results 2025/26
Ypsomed grows 20 % in core business and wins record number of customer projects
- Growth of 33.6 % in commercial autoinjectors sale;
- Successful completion of the sale of mylife Diabetes Care AG (formerly Ypsomed Diabetes Care AG) and Ypsotec AG;
- Phase-out of Delivery Systems Contract Manufacturing initiated;
- Acquisition of US manufacturing facility in Holly Springs, North Carolina;
- Successful completion of the CHF 150 million share buyback program;
- Launch of three new product platforms: YpsoLoop, YpsoDot, and YpsoFlow.
Ypsomed grows 20 % in core business and wins record number of customer projects
- Growth of 33.6 % in commercial autoinjectors sale;
- Successful completion of the sale of mylife Diabetes Care AG (formerly Ypsomed Diabetes Care AG) and Ypsotec AG;
- Phase-out of Delivery Systems Contract Manufacturing initiated;
- Acquisition of US manufacturing facility in Holly Springs, North Carolina;
- Successful completion of the CHF 150 million share buyback program;
- Launch of three new product platforms: YpsoLoop, YpsoDot, and YpsoFlow.
View previous video statements
- Video statement quarterly Q3 2025/26
- Video statement semiannual results 2025/26
- Video statement annual results 2024/25
- Video statement semiannual results 2024/25
- Video statement annual results 2023/24
- Video statement semiannual results 2023/24
- Video statement annual results 2022/23
- Video statement annual results 2021/22
- Video statement semiannual results 2021/22
- Video statement annual results 2020/21
- Video statement semiannual results 2020/21
- Video statement annual results 2019/20
- Video statement annual results 2018/19